Chime Financial Inc (CHYM)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
$33.76+0.33%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
Intact: The reason to own it still holds.
Chime aims to grow revenue by about 22% to 23% in 2026. The company raised revenue guidance to $2.67 billion for 2026. It has announced a $200 million share buyback program. Recent earnings beats show improving execution.
Chime is still loss-making with elevated risk. Revenue growth could slow below 22%. The company missed earnings in Q2 2025, showing execution risks remain.
The market expects about 24% revenue growth, slightly above management's 22-23% target. Our fair value is near $12.38, close to consensus price targets, reflecting moderate optimism on growth and turnaround progress.
Breaks if: EPS falls below $0.25 in FY26
Breaks if: YoY revenue growth falls below 20% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on growth and profitability. The current thesis state indicates a cautious optimism, as recent performance has improved but risks remain elevated.
The market appears to have priced in a justified valuation with a low expectations gap. CHYM is currently trading at a premium compared to its peers, suggesting that some positive developments are already reflected in its valuation.
Management is on track to achieve strong revenue growth and profitability, with recent results showing a significant year-over-year revenue increase. However, there is a near-term risk of earnings misses due to erratic performance in the industry.
The long-term outlook hinges on management's ability to maintain guidance and deliver on growth targets. Additionally, external factors such as Fed rate cuts and performance of sector leaders will play a critical role in shaping CHYM's trajectory.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the read on CHYM. However, the CEO selling $3.4 million in shares may signal a lack of confidence.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Drive strong top-line growth through product launches, member engagement, and expanding employer partnerships to achieve 25%-27% revenue growth in 2026.
Breaks if: Buyback program is canceled or materially delayed
In the next 1 to 3 years, CHYM's performance will depend on its execution of growth strategies and external economic conditions. Not investment advice.